SAN FRANCISCO, December 2018 – US Capital Global Securities, an affiliate of US Capital Global, is offering to accredited investors a $5 million preferred equity investment in the privately held medical device company, EDP Biotech Corporation (“EDP Biotech”). Click...

By Tom Ballard, Chief Alliance Officer, PYA More good news for EDP BioTech Corporation, the Knoxville-based company developing products for early detection of diseases starting with colon cancer. In fact, there are two announcements. About a month after returning from...

By Tom Ballard, Chief Alliance Officer, PYA It was back to China last week for Eric Mayer, Chief Executive Officer of EDP BioTech Corporation. The trip was to participate in the finals of the “InnoSTARS Competition” held in Suzhou, China. ... EDP BioTech was founded...

Seeking Alpha Exact Sciences: Can It Make Colonoscopies A Thing Of The Past? Summary Colorectal cancer and the market for screening for this cancer is huge. I believe that Non-colonoscopy methods available to screening will become the norm as they are cheaper, and...

Eric Mayer is headed to China next month. Tom Ballard, Chief Alliance Officer, PYA has recently had a chat with Eric, CEO of EDP Biotech. This month we are excited to report that EDP Biotech has been invited to the InnoSTARS Competition Semi-Final fro...